Protein Sequencing Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Protein sequencing refers to the determination of amino acid sequences in protein molecules, a fundamental process in proteomics, drug discovery, and biomedical research. The global market includes technologies such as mass spectrometry, Edman degradation, and liquid chromatography coupled with tandem mass spectrometry. Valued at approximately $1.85 billion in 2025, this specialized analytical market serves pharmaceutical companies, contract research organizations, academic institutions, and clinical laboratories.

• •Market encompasses protein identification, quantification, and characterization technologies
• •Serves pharmaceutical R&D, clinical diagnostics, and academic research sectors
• •Estimated at $1.85 billion globally in 2025 with steady long-term growth trajectory

Expanding biopharmaceutical pipelines and rising investment in precision medicine are primary market catalysts. The growing complexity of biologic therapeutics, including monoclonal antibodies and biosimilars, creates sustained demand for advanced protein characterization capabilities. Increased proteomics research funding, coupled with technological improvements in mass spectrometry speed and accuracy, is broadening adoption across research and clinical settings.

• •Biopharmaceutical pipeline expansion driving demand for protein characterization
• •Precision medicine and personalized therapy initiatives increasing proteomics research spending
• •Technological advances in mass spectrometry lowering barriers to adoption

The market is typically segmented by technology type, application area, and end-user. Mass spectrometry-based platforms dominate due to their accuracy and throughput advantages. North America leads in market share due to substantial pharmaceutical R&D investment and established academic infrastructure, while the Asia-Pacific region represents the fastest-growing segment as research capabilities expand across China, Japan, and South Korea.

• •Mass spectrometry segment holds the largest technology share
• •North America accounts for the dominant regional market portion
• •Asia-Pacific emerging as highest-growth regional market

What are the recent trends and outlook?

The market is evolving toward higher-throughput, more automated platforms capable of handling complex protein mixtures. Artificial intelligence and machine learning integration are beginning to enhance protein sequence prediction and data analysis capabilities. Looking forward, sustained growth is expected as biologics-based therapeutics continue gaining share in drug development, and as clinical proteomics applications expand into precision oncology and rare disease diagnostics.

• •AI-assisted protein sequencing and data analysis gaining research traction
• •Clinical proteomics applications expanding in oncology and diagnostic testing
• •Anticipated steady growth aligned with expanding biologics development pipelines